Patent application number | Description | Published |
20090074896 | Extracts of Polygonum multiflorum Thunb, and preparation process and uses of the same - Disclosed herein are processes for preparing extract products from the root of | 03-19-2009 |
20090092697 | Extracts of polygonum multiflorum thunb., and preparation process and uses of the same - Disclosed herein are processes for preparing extract products from the root of | 04-09-2009 |
20090137631 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REGULATION OF G- AND/OR GC-RICH NUCLEIC ACID EXPRESSION - Methods and pharmaceutical compositions for regulations of Guanosine- (G-) and/or Guanosine-cytosine-rich (GC-rich) nucleic acid expressions are provided. The methods include a step of interacting the G- and/or GC-rich region of the nucleic acid with thalidomide, and the pharmaceutical compositions include the thalidomide and a pharmaceutical carrier. | 05-28-2009 |
20090208595 | Extract of plant Dendrobii caulis and preparing process thereof - An extract of plant | 08-20-2009 |
20100160243 | COMPOUNDS AND METHODS FOR ENHANCING ERYTHROPOIESIS - Compounds and methods for enhancing erythropoiesis. The compound contains a chemical structure of the formula (I) indicated below, in which R is a glucosyl group. In addition to having an erythropoiesis effect, the compound of the formula (1) is effective in enhancing erythropoietin formation, and increasing kidney function and expression of hepatocyte growth factor. The method includes the step of administering an effective amount of the compound of the formula (I) to a subject in need thereof and thereby results in an enhancement of erythropoiesis. | 06-24-2010 |
20110003761 | BIOLOGICALLY ACTIVE EXTRACT FROM DENDROBIUM PLANT, USE THEREOF AND PROCESS FOR PREPARING THE SAME - A substance having the following formula is provided. | 01-06-2011 |
20110123648 | USE OF COCONUT WATER EXTRACT OR COCONUT SHELL EXTRACT FOR TREATING IMMUNOLOGICAL DISEASES AND/OR DISORDERS - A method for treating immunological diseases and/or disorders associated with tumor necrosis factor-alpha (TNF-α) in a subject in need thereof is disclosed. The method comprises administering to a subject in need thereof a therapeutically effective amount of the coconut ( | 05-26-2011 |
20130316967 | COMPOUNDS AND METHODS FOR ENHANCING ERYTHROPOIESIS - Compounds and methods for enhancing erythropoiesis. The compound contains a chemical structure of the formula (I) indicated below, in which R is a glucosyl group. In addition to having an erythropoiesis effect, the compound of the formula (I) is effective in enhancing erythropoietin formation, and increasing kidney function and expression of hepatocyte growth factor. The method includes the step of administering an effective amount of the compound of the formula (I) to a subject in need thereof and thereby results in an enhancement of erythropoiesis. | 11-28-2013 |
20140147464 | METHOD AND COMPOSITION FOR INDUCING AUTOPHAGY - A method for inducing autophagy in a subject having an autophagy defect is provided. The method of the present invention includes the step of administering to the subject a therapeutically effective amount of a | 05-29-2014 |
20140294979 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REGULATION OF G- AND/OR GC-RICH NUCLEIC ACID EXPRESSION - Methods and pharmaceutical compositions for regulations of Guanosine- (G-) and/or Guanosine-cytosine-rich (GC-rich) nucleic acid expressions are provided. The methods include a step of interacting the G- and/or GC-rich region of the nucleic acid with thalidomide, and the pharmaceutical compositions include the thalidomide and a pharmaceutical carrier. | 10-02-2014 |
20140296175 | COMPOSITION AND METHOD FOR INDUCING EPO-MEDIATED HAEMOGLOBIN EXPRESSION AND MITOCHONDRIAL BIOGENESIS IN NONHAEMATOPOIETIC CELL - A composition for inducing erythropoietin (EPO)-mediated haemoglobin (Hb) expression in a nonhaematopoietic cell of a subject is provided. The composition includes a compound represented by formula (I), wherein R is a glycosyl group; and a pharmaceutical acceptable carrier. | 10-02-2014 |